Price (delayed)
$0.3701
Market cap
$38.78M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.3
Enterprise value
$73.33M
Recro Pharma Inc. is a contract development and manufacturing organization (CDMO) with capabilities from early feasibility to commercial manufacturing. With an expertise in solving complex manufacturing problems, Recro is a
There are no recent dividends present for SCTL.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.